ArticleAdvances in experimental medicine and biology2021
Rare Coding Variants Associated with Breast Cancer.
Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most common invasive cancer in females worldwide and in Asian countries. Common variants found by genome-wide association studies (GWAS) only explain approximately 16% of the heritability of breast cancer: therefore, it is important to examine rare/low-frequency variants in GWAS-identified loci which may also contribute to breast cancer risk. Previous studies have reported that genetic variants with lower allele frequency are more likely to be functional than common variants in coding regions. In future studies, the contribution of observed rare variants will be estimated more clearly when additive and recessive genetic variants will be investigated using sequencing technology, eQTL studies, and improved statistical methods in large samples.
Indexed as
Identifiers
33983593What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.